Skip Navigation
 

2018 PHARMACOGENOMICS (PGx) CERTIFICATION:

Application of Pharmacogenetics/Pharmacogenomics to Pharmacy Practice


 

 

Date: Friday, October 26th, 2018

Location: Manchester University College of Pharmacy, FT. Wayne IN

Cost: $275 IPA Member, $300 Non-Member per person

Hightlights: 

  • FACULTY (3):  David E. Bright, BS, PharmD, BCACP, RPh. and
  • Thomas Smith, PharmD, BCPP, RPh. and
  • David F. Kisor, BS, PharmD, FCP, RPh.
  • This program consists of home self-paced-self-study (approximately four to six weeks) and a live half-day session (Oct. 26, 2018)
  • Book and Study Guide included by email

 

REGISTration is closed

 

Featured Faculty

David R. Bright, BS, PharmD, BCACP, RPh

Associate Professor of Pharmacy Practice

Ferris State University College of Pharmacy

220 Ferris Dr, Big Rapids, MI 49307

davidbright@ferris.edu

Phone: 231.591.2231

Dr. Bright is an Associate Professor of Pharmacy at Ferris State University. He received his PharmD degree from the University of Toledo (UT) and subsequently completed a community pharmacy residency with Kroger Pharmacy and UT. Dr. Bright then spent five years on the faculty at the Ohio Northern University, where he taught in areas of therapeutics and medication therapy management (MTM), and also directed a community pharmacy residency program. Dr. Bright’s area of research has primarily involved the pragmatic implementation and improvement of non-dispensing pharmacy services, particularly in the outpatient setting. Most recently, that has involved the integration of pharmacogenomics into clinical practice via MTM. Associated work has also involved education of pharmacists and pharmacy students as to pharmacogenomic principles and the application to clinical practice.

 

Thomas Smith, PharmD, BCPP, RPh

Associate Professor of Pharmacy Practice and Pharmacogenomics

Manchester University

College of Pharmacy, Natural and Health Sciences

10627 Diebold Rd., Fort Wayne, IN 46845

Trsmith03@manchester.edu

Phone: 260-470-2671

Dr. Smith is an assistant professor within the Pharmacy Practice Department with responsibilities in the PharmD and Master of Science in Pharmacogenomics (MS in PGx) Programs at Manchester University.  As co-chair of the MS in PGx implementation committee at Manchester, he contributed to the creation and implementation of the MS in PGx Program. He teaches pharmacy and MS in PGx students in both didactic and experiential settings and is a psychiatric care pharmacy specialist within a large, acute care facility.  In addition, he has sat on the pharmacogenomics working group at a large community medical center and has numerous scholarly work and presentations relating to pharmacogenomics in recent years.  His interests include precision medicine for psychiatric illness encompassing its entire spectrum, from its documentation to its discovery and application.

 

David F. Kisor, BS, PharmD, FCP, RPh

Professor of Pharmaceutical Sciences and Pharmacogenomics

Director of Pharmacogenomics Education

Manchester University

College of Pharmacy, Natural and Health Sciences

10627 Diebold Rd., Fort Wayne, IN 46845

dfkisor@manchester.edu

Phone: 260-470-2747

Dr. Kisor is Professor and Chair of Pharmaceutical Sciences and is the Director of the Master of Science in Pharmacogenomics Program at the Manchester University College of Pharmacy in Fort Wayne, IN. He joined Manchester in June 2014, and is responsible for facilitating teaching, scholarly activity, and service in the Department of Pharmaceutical Sciences. He has integrated PGt into pharmacokinetic subject matter since 1998. His research is related to the pharmacokinetics and pharmacogenomics of various compounds in the in-vitro and in-vivo settings. Dr. Kisor has more than 50 peer reviewed publications and is the lead author of the textbook “Pharmacogenetics, kinetics, and dynamics, for personalized medicine” and the updated version “Pharmacogenes: Scientific Background and Clinical Applications”. He is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), American Society for Clinical Pharmacology and Therapeutics (ASCPT), the American College of Clinical Pharmacology (ACCP), the American Pharmacists Association (APhA), the American Association of Colleges of Pharmacy (AACP), and the Personalized Medicine Coalition (PMC). Dr. Kisor is a past chair of the Pharmacogenetics Special Interest Group of AACP. He was named a Fellow of ACCP in 2017.

 

PGx Certification Program

Program Brief Description: The IPA-MU PGx Program aims to educate pharmacists/student pharmacists and other healthcare providers and educators on the science and application of pharmacogenetics/pharmacogenomics.

Precision medicine is advancing and pharmacists are at the forefront. Leadership and expertise in PGx is needed to increase uptake and expand PGx across healthcare setting. This program will elevate your knowledge base in PGx and provide the background needed to start applying this advanced care to optimize drug therapy.

Goal and Objectives

1. Goal Statement: The goal of this program is to educate pharmacists/student pharmacists and other healthcare providers and educators on the science and application of pharmacogenetics/pharmacogenomics.

2. Objectives:

After completing the home (self)-study activity, pharmacists will be able to:

  1. Define pharmacogenetics (PGt), pharmacogenomics (PGx), and the related nomenclature.
  2. Explain the scientific basis of genetic influence on pharmacokinetics (PK) and pharmacodynamics (PD) related to drug and or drug dose selection.
  3. Illustrate the collection of patient DNA samples for PGt/PGx testing.
  4. Interpret PGt/PGx test results.

After completing the live program activity, pharmacists will be able to:

  1. Identify drug-gene, and drug-drug-gene interactions relative to medication lists.
  2. Associate genetic and non-genetic factors which defines a patient’s phenotype relative to response to medication therapy.
  3. Recommend specific alternate therapies and/or doses of specific medications based on PGt/PGx test results.
  4. Relate pharmacist competencies in PGt/PGx to science and application.

3. The home (self)-study will be 12 hours. Here, three hours are related to basic science, pharmacokinetics, and pharmacodynamics and 10 hours are related to specific drug-gene interactions.

4. The live program will be four hours. Here the focus will be on application utilizing “standardized patients”.

5. The title will be “Applications of Pharmacogenetics/Pharmacogenomics in Pharmacy Practice”.

 
 

 

 

.